Himax Technologies, Inc. to Attend BofA Securities 2023
TAINAN, Taiwan, March 01, 2023 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a
Globe Newswire1-03-2023, 15:45
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers 17-06-2024, 17:00